Achilles Therapeutics Plc Stock Fundamentals
ACHLDelisted Stock | USD 1.48 0.01 0.68% |
Achilles Therapeutics PLC fundamentals help investors to digest information that contributes to Achilles Therapeutics' financial success or failures. It also enables traders to predict the movement of Achilles Stock. The fundamental analysis module provides a way to measure Achilles Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Achilles Therapeutics stock.
Achilles |
Achilles Therapeutics PLC Company Shares Owned By Insiders Analysis
Achilles Therapeutics' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Achilles Therapeutics Shares Owned By Insiders | 6.28 % |
Most of Achilles Therapeutics' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Achilles Therapeutics PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition |
Based on the latest financial disclosure, 6.28% of Achilles Therapeutics PLC are shares owned by insiders. This is 58.63% lower than that of the Biotechnology sector and 55.71% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 37.76% higher than that of the company.
Achilles Therapeutics PLC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Achilles Therapeutics's current stock value. Our valuation model uses many indicators to compare Achilles Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Achilles Therapeutics competition to find correlations between indicators driving Achilles Therapeutics's intrinsic value. More Info.Achilles Therapeutics PLC is rated fourth in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Achilles Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Achilles Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Achilles Therapeutics' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Achilles Therapeutics could also be used in its relative valuation, which is a method of valuing Achilles Therapeutics by comparing valuation metrics of similar companies. Achilles Therapeutics is currently under evaluation in shares owned by insiders category among its peers.
Achilles Fundamentals
Return On Equity | -0.52 | ||||
Return On Asset | -0.3 | ||||
Current Valuation | (19.21 M) | ||||
Shares Outstanding | 41.1 M | ||||
Shares Owned By Insiders | 6.28 % | ||||
Shares Owned By Institutions | 83.09 % | ||||
Number Of Shares Shorted | 797.85 K | ||||
Price To Earning | 0.49 X | ||||
Price To Book | 0.59 X | ||||
EBITDA | (70.44 M) | ||||
Net Income | (69.94 M) | ||||
Cash And Equivalents | 201.6 M | ||||
Cash Per Share | 4.94 X | ||||
Total Debt | 4.62 M | ||||
Debt To Equity | 0.04 % | ||||
Current Ratio | 11.45 X | ||||
Book Value Per Share | 2.51 X | ||||
Cash Flow From Operations | (48.45 M) | ||||
Short Ratio | 0.23 X | ||||
Earnings Per Share | (1.66) X | ||||
Price To Earnings To Growth | (0.31) X | ||||
Target Price | 0.5 | ||||
Number Of Employees | 204 | ||||
Beta | 1.25 | ||||
Market Capitalization | 63.22 M | ||||
Total Asset | 161.46 M | ||||
Retained Earnings | (259.95 M) | ||||
Working Capital | 128.64 M | ||||
Net Asset | 161.46 M |
About Achilles Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Achilles Therapeutics PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Achilles Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Achilles Therapeutics PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company was founded in 2016 and is headquartered in London, the United Kingdom. Achilles Therapeutics is traded on NASDAQ Exchange in the United States.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Achilles Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Achilles Stock
If you are still planning to invest in Achilles Therapeutics PLC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Achilles Therapeutics' history and understand the potential risks before investing.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |